BioAtla, Inc.
BCAB
$0.87
$0.045.18%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 0.00 | 11.00M | 11.00M | 11.00M | 11.00M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 0.00 | 11.00M | 11.00M | 11.00M | 11.00M |
| Cost of Revenue | 34.11M | 40.97M | 41.56M | 48.06M | 59.09M |
| Gross Profit | -34.11M | -29.97M | -30.56M | -37.06M | -48.09M |
| SG&A Expenses | 19.07M | 20.69M | 21.50M | 21.85M | 23.12M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 66.29M | 74.78M | 78.10M | 84.94M | 97.24M |
| Operating Income | -66.29M | -63.78M | -67.10M | -73.94M | -86.24M |
| Income Before Tax | -64.71M | -59.52M | -61.88M | -69.78M | -81.82M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -64.71 | -59.52 | -61.88 | -69.78 | -81.82 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -64.71M | -59.52M | -61.88M | -69.78M | -81.82M |
| EBIT | -66.29M | -63.78M | -67.10M | -73.94M | -86.24M |
| EBITDA | -65.71M | -63.02M | -66.23M | -73.02M | -85.17M |
| EPS Basic | -1.15 | -1.10 | -1.22 | -1.44 | -1.70 |
| Normalized Basic EPS | -0.72 | -0.69 | -0.76 | -0.90 | -1.06 |
| EPS Diluted | -1.15 | -1.10 | -1.22 | -1.44 | -1.70 |
| Normalized Diluted EPS | -0.72 | -0.69 | -0.76 | -0.90 | -1.06 |
| Average Basic Shares Outstanding | 225.15M | 214.74M | 204.45M | 194.29M | 192.63M |
| Average Diluted Shares Outstanding | 225.15M | 214.74M | 204.45M | 194.29M | 192.63M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |